Skip to main content
MD

Molecular Designs

The startup develops multiplex assays for molecular testing that enable rapid and specific identification of infectious pathogens. This technology enhances the accuracy and timeliness of pathogen detection, addressing the critical need for effective near-to-point testing in healthcare settings.

Birmingham, United KingdomFounded 2019521K+ followers
Updated 3 months ago

Funding

$40M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional pathogen detection methods can be slow and lack the specificity needed for timely and accurate diagnosis of infectious diseases. This can lead to delays in treatment, increased healthcare costs, and potentially poorer patient outcomes, especially in near-to-point testing scenarios.

Solution

Molecular Designs develops and provides multiplex PCR assays and related products for rapid and specific identification of infectious pathogens. Their Simplicity Panels™ offer customizable, pre-plated PCR assays that minimize waste and expedite lab workflows. In addition to assays, Molecular Designs provides solutions for sample collection, nucleic acid extraction, and lab information management, creating an integrated workflow for molecular testing. The company's products are designed to be cost-effective and easy to use, enabling laboratories to improve efficiency and reduce costs associated with PCR testing.

Target Audience

The primary target audience includes clinical laboratories, research institutions, and healthcare providers seeking rapid, accurate, and cost-effective solutions for molecular diagnostics and pathogen detection.

Features

  • Simplicity Panels™: Customizable, pre-plated PCR assays for various pathogens.
  • Opti-Swab Liquid Amies Transport System: Innovative solution for reliable collection and transport of viral and bacterial pathogens.
  • Rapid Extraction System: Automated nucleic acid extraction system using magnetic bead technology.
  • Simplicity Connect: Cloud-based LIS for automating workflows and integrating lab data.
  • Extensive Assay Library: A wide range of assays available, including those for gastrointestinal pathogens, Candida auris, and urinary tract microbiota.
  • Direct PCR: Extractionless PCR testing.
This profile is AI-generated and may contain inaccuracies.